Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice
| Autor: | Aleksandra Marinkovic-Petrovic, Marie-France del Guercio, Drew Hannaman, Jeff Alexander, Erika Assarsson, Scott Southwood, Stephani Stewart, Glenn Ishioka, Les Walker, Alessandro Sette, Mark Newman, Lo Vang, Claire Crimi, Pamuk Bilsel, Jason Botten, Vivek Chitnis |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Epitopes
T-Lymphocyte Mice Transgenic Antibodies Viral medicine.disease_cause Article Epitope Virus DNA vaccination Mice Influenza Human Vaccines DNA Influenza A virus medicine Animals Humans Cells Cultured Conserved Sequence General Veterinary General Immunology and Microbiology biology Immunogenicity Public Health Environmental and Occupational Health virus diseases HLA-DR Antigens Survival Analysis Virology Influenza A virus subtype H5N1 Vaccination Infectious Diseases Influenza Vaccines Leukocytes Mononuclear biology.protein Molecular Medicine Antibody Peptides Protein Binding |
| Zdroj: | Vaccine. 28:664-672 |
| ISSN: | 0264-410X |
| Popis: | The goal of the present study was to design a vaccine that would provide universal protection against infection of humans with diverse influenza A viruses. Accordingly, protein sequences from influenza A virus strains currently in circulation (H1N1, H3N2), agents of past pandemics (H1N1, H2N2, H3N2) and zoonotic infections of man (H1N1, H5N1, H7N2, H7N3, H7N7, H9N2) were evaluated for the presence of amino acid sequences, motifs, that are predicted to mediate peptide epitope binding with high affinity to the most frequent HLA-DR allelic products. Peptides conserved among diverse influenza strains were then synthesized, evaluated for binding to purified HLA-DR molecules and for their capacity to induce influenza-specific immune recall responses using human donor peripheral blood mononuclear cells (PBMC). Accordingly, 20 epitopes were selected for further investigation based on their conservancy among diverse influenza strains, predicted population coverage in diverse ethnic groups and capacity to recall influenza-specific responses. A DNA plasmid encoding the epitopes was constructed using amino acid spacers between epitopes to promote optimum processing and presentation. Immunogenicity of the DNA vaccine was measured using HLA-DR4 transgenic mice and the TriGrid in vivo electroporation device. Vaccination resulted in peptide-specific immune responses, augmented HA-specific antibody responses and protection of HLA-DR4 transgenic mice from lethal PR8 influenza virus challenge. These studies demonstrate the utility of this vaccine format and the contribution of CD4(+) T cell responses to protection against influenza infection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect